BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20080329)

  • 1. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer.
    Six L; Polterauer S; Grimm C; Seebacher V; Tempfer C; Heinze G; Joura E; Reinthaller A; Hefler LA
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):217-21. PubMed ID: 17459567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
    Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
    Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of plasma fibrinogen levels on patients with vulvar cancer.
    Seebacher V; Polterauer S; Grimm C; Tempfer C; Hefler-Frischmuth K; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):88-91. PubMed ID: 22310943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
    Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein is a prognostic parameter in patients with cervical cancer.
    Polterauer S; Grimm C; Tempfer C; Sliutz G; Speiser P; Reinthaller A; Hefler LA
    Gynecol Oncol; 2007 Oct; 107(1):114-7. PubMed ID: 17617445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma.
    Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Tanaka H; Miki K; Kobayashi K; Morita K
    Surgery; 2008 Nov; 144(5):729-35. PubMed ID: 19081014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the role of inflammation in renal cancer.
    Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
    Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer.
    Sharma R; Hook J; Kumar M; Gabra H
    Eur J Cancer; 2008 Jan; 44(2):251-6. PubMed ID: 18155897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L; Tempfer C; Obermair A; Frischmuth K; Sliutz G; Reinthaller A; Leodolter S; Kainz C
    Clin Cancer Res; 1999 Oct; 5(10):2806-9. PubMed ID: 10537345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer.
    Schmid M; Schneitter A; Hinterberger S; Seeber J; Reinthaller A; Hefler L
    Obstet Gynecol; 2007 Dec; 110(6):1231-6. PubMed ID: 18055714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
    Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
    Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer.
    Ramsey S; Lamb GW; Aitchison M; Graham J; McMillan DC
    Cancer; 2007 Jan; 109(2):205-12. PubMed ID: 17149754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.
    Hefler LA; Concin N; Hofstetter G; Marth C; Mustea A; Sehouli J; Zeillinger R; Leipold H; Lass H; Grimm C; Tempfer CB; Reinthaller A
    Clin Cancer Res; 2008 Feb; 14(3):710-4. PubMed ID: 18245530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.